T1	Participants 88 127	patients with type II diabetes mellitus
T2	Participants 273 318	Asymptomatic, obese, insulin-treated patients
T3	Participants 366 420	half of these patients, insulin therapy was withdrawn.
T4	Participants 438 525	patients developing hyperglycemic symptoms or acetonemia were counted as study failures
T5	Participants 566 593	insulin-withdrawal patients
T6	Participants 653 679	two of 24 control subjects
T7	Participants 782 850	insulin-withdrawal patients who did not meet study failure criteria,
T8	Participants 870 886	control patients
T9	Participants 888 925	Study patients were insulin deficient
T10	Participants 1077 1103	insulin-deficient patients
